Effects of CpG Methylation on Recognition of DNA by the Tumour Suppressor p53

Journal of Molecular Biology

Volumn 386, Issue 1, 2009, Pages 72-80

  Petrovich, Miriana ^a   Veprintsev, Dmitry B ^b  

^a MRC CENTRE FOR PROTEIN ENGINEERING   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

CpG; DNA binding; DNA methylation; fluorescence anisotropy; p53

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOSINE; DNA; DNA BINDING PROTEIN; PROTEIN P53;

AMINO ACID SUBSTITUTION; ANISOTROPY; ARTICLE; BINDING AFFINITY; BINDING SITE; DNA DETERMINATION; DNA METHYLATION; DNA SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; STRESS;

EID: 58549110607     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.11.054     Document Type: Article

References (42)

1. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 6 (2005) 597-610
2. Brena R.M., and Costello J.F. Genome-epigenome interactions in cancer. Hum. Mol. Genet. 16 Spec. No. 1 (2007) R96-R105
3. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16 (2002) 6-21
4. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
5. Watt F., and Molloy P.L. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 2 (1988) 1136-1143
6. Bird A.P., and Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 99 (1999) 451-454
7. Kanduri C., Pant V., Loukinov D., Pugacheva E., Qi C.F., Wolffe A., Ohlsson R., and Lobanenkov V.V. Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive. Curr. Biol. 10 (2000) 853-856
8. Klose R.J., and Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31 (2006) 89-97
9. Holler M., Westin G., Jiricny J., and Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev. 2 (1988) 1127-1135
10. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 452 (2008) 45-50
11. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
12. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2 (2002) 594-604
13. Joerger A.C., and Fersht A.R. Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene 26 (2007) 2226-2242
14. Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S.V., Hainaut P., and Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28 (2007) 622-629
15. El-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat. Genet. 1 (1992) 45-49
16. Tomso D.J., Inga A., Menendez D., Pittman G.S., Campbell M.R., Storici F., et al. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc. Natl Acad. Sci. USA 102 (2005) 6431-6436
17. Oshiro M.M., Futscher B.W., Lisberg A., Wozniak R.J., Klimecki W.T., Domann F.E., and Cress A.E. Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia 7 (2005) 799-808
18. Wang W., Huper G., Guo Y., Murphy S.K., Olson Jr. J.A., and Marks J.R. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene 24 (2005) 2705-2714
19. Futscher B.W., Oshiro M.M., Wozniak R.J., Holtan N., Hanigan C.L., Duan H., and Domann F.E. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31 (2002) 175-179
20. Veprintsev D.B., and Fersht A.R. Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA. Nucleic Acids Res. 36 (2008) 1589-1598
21. Weinberg R.L., Veprintsev D.B., and Fersht A.R. Cooperative binding of tetrameric p53 to DNA. J. Mol. Biol. 341 (2004) 1145-1159
22. Weinberg R.L., Freund S.M., Veprintsev D.B., Bycroft M., and Fersht A.R. Regulation of DNA binding of p53 by its C-terminal domain. J. Mol. Biol. 342 (2004) 801-811
23. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
24. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116 (2004) 499-509
25. Kaneshiro K., Tsutsumi S., Tsuji S., Shirahige K., and Aburatani H. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 89 (2007) 178-188
26. Menendez D., Krysiak O., Inga A., Krysiak B., Resnick M.A., and Schonfelder G. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc. Natl Acad. Sci. USA 103 (2006) 1406-1411
27. Smeenk L., van Heeringen S.J., Koeppel M., Driel M.A., Bartels S.J., Akkers R.C., et al. Characterization of genome-wide p53-binding sites upon stress response. Nucleic Acids Res. 36 (2008) 3639-3654
28. Qian H., Wang T., Naumovski L., Lopez C.D., and Brachmann R.K. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21 (2002) 7901-7911
29. Lim Y.P., Lim T.T., Chan Y.L., Song A.C., Yeo B.H., Vojtesek B., et al. The p53 knowledgebase: an integrated information resource for p53 research. Oncogene 26 (2007) 1517-1521
30. Inga A., Storici F., Darden T.A., and Resnick M.A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol. 22 (2002) 8612-8625
31. Ma B., Pan Y., Zheng J., Levine A.J., and Nussinov R. Sequence analysis of p53 response-elements suggests multiple binding modes of the p53 tetramer to DNA targets. Nucleic. Acids. Res. 35 (2007) 2986-3001
32. Goodrich D.W. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 25 (2006) 5233-5243
33. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4 (2003) 915-925
34. Bentley D.R., Balasubramanian S., Swerdlow H.P., Smith G.P., Milton J., Brown C.G., et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456 (2008) 53-59
35. Pomraning K.R., Smith K.M., and Freitag M. Genome-wide high throughput analysis of DNA methylation in eukaryotes. Methods (2008) [Epub ahead of print]. doi:10.1016/j.ymeth.2008.09.022
36. Down T.A., Rakyan V.K., Turner D.J., Flicek P., Li H., Kulesha E., et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat. Biotechnol. 26 (2008) 779-785
37. Gaston K., and Fried M. CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucleic Acids Res. 23 (1995) 901-909
38. Oshiro M.M., Watts G.S., Wozniak R.J., Junk D.J., Munoz-Rodriguez J.L., Domann F.E., and Futscher B.W. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 22 (2003) 3624-3634
39. Ehrlich M., Gama-Sosa M.A., Huang L.H., Midgett R.M., Kuo K.C., McCune R.A., and Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 10 (1982) 2709-2721
40. Nikolova P.V., Henckel J., Lane D.P., and Fersht A.R. Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc. Natl Acad. Sci. USA 95 (1998) 14675-14680
41. Joerger A.C., Allen M.D., and Fersht A.R. Crystal structure of a superstable mutant of human p53 core domain: insights into the mechanism of rescuing oncogenic mutations. J. Biol. Chem. 279 (2004) 1291-1296
42. Veprintsev D.B., Freund S.M., Andreeva A., Rutledge S.E., Tidow H., Canadillas J.M., et al. Core domain interactions in full-length p53 in solution. Proc. Natl Acad. Sci. USA 103 (2006) 2115-2119